Drug General Information |
Drug ID |
D00RIX
|
Former ID |
DNC004714
|
Drug Name |
APIGENIN
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C15H10O5
|
InChI |
InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H
|
InChIKey |
KZNIFHPLKGYRTM-UHFFFAOYSA-N
|
PubChem Compound ID |
|
PubChem Substance ID |
4649, 121464, 597182, 3157885, 7548407, 7985171, 8143786, 8149149, 8616271, 10319029, 10321674, 10852035, 11108249, 11110728, 11110729, 11113975, 11120256, 11120744, 11121232, 11335973, 11361212, 11372984, 11375697, 11446182, 11462184, 11466442, 11467562, 11484152, 11486043, 11488244, 11491697, 11493813, 11537389, 14750506, 17389511, 17404628, 24278212, 24846790, 25622500, 26613049, 26679908, 26747161, 26747162, 26752115, 26752116, 26758236, 29203847, 39289566, 46500336, 46501293
|
Target and Pathway |
Target(s) |
Neuraminidase |
Target Info |
Inhibitor |
[2]
|
Casein kinase II, alpha chain |
Target Info |
Inhibitor |
[3]
|
Aldose reductase |
Target Info |
Inhibitor |
[4]
|
Cytochrome P450 1B1 |
Target Info |
Inhibitor |
[5]
|
Cytochrome P450 19 |
Target Info |
Inhibitor |
[6]
|
mRNA of androgen receptor |
Target Info |
Inhibitor |
[7]
|
Cyclin-dependent protein kinase Pfmrk |
Target Info |
Inhibitor |
[8]
|
Cell division protein kinase 6 |
Target Info |
Inhibitor |
[9]
|
Estradiol 17 beta-dehydrogenase 1 |
Target Info |
Inhibitor |
[10]
|
BioCyc Pathway
|
Methylglyoxal degradation III
|
Acetone degradation I (to methylglyoxal)PWY66-401:Superpathway of tryptophan utilization
|
Superpathway of melatonin degradation
|
Melatonin degradation IPWY-7305:Superpathway of steroid hormone biosynthesis
|
Estradiol biosynthesis II
|
Estradiol biosynthesis IPWY-7305:Superpathway of steroid hormone biosynthesis
|
Estradiol biosynthesis I
|
KEGG Pathway
|
Other glycan degradationhsa03008:Ribosome biogenesis in eukaryotes
|
NF-kappa B signaling pathway
|
Wnt signaling pathway
|
Adherens junction
|
Tight junction
|
Measles
|
Herpes simplex infection
|
Epstein-Barr virus infectionhsa00040:Pentose and glucuronate interconversions
|
Fructose and mannose metabolism
|
Galactose metabolism
|
Glycerolipid metabolism
|
Metabolic pathwayshsa00140:Steroid hormone biosynthesis
|
Tryptophan metabolism
|
Metabolism of xenobiotics by cytochrome P450
|
Ovarian steroidogenesis
|
Chemical carcinogenesis
|
MicroRNAs in cancerhsa00140:Steroid hormone biosynthesis
|
Metabolic pathways
|
Ovarian steroidogenesishsa04114:Oocyte meiosis
|
Pathways in cancer
|
Prostate cancerhsa04110:Cell cycle
|
p53 signaling pathway
|
PI3K-Akt signaling pathway
|
Hepatitis B
|
Viral carcinogenesis
|
MicroRNAs in cancer
|
Pancreatic cancer
|
Glioma
|
Melanoma
|
Chronic myeloid leukemia
|
Small cell lung cancer
|
Non-small cell lung cancerhsa00140:Steroid hormone biosynthesis
|
NetPath Pathway
|
FSH Signaling PathwayNetPath_13:IL1 Signaling Pathway
|
TGF_beta_Receptor Signaling PathwayNetPath_23:TSH Signaling Pathway
|
IL4 Signaling Pathway
|
TGF_beta_Receptor Signaling PathwayNetPath_25:FSH Signaling PathwayNetPath_4:EGFR1 Signaling Pathway
|
AndrogenReceptor Signaling Pathway
|
FSH Signaling PathwayNetPath_7:TGF_beta_Receptor Signaling PathwayNetPath_25:FSH Signaling Pathway
|
PANTHER Pathway
|
Androgen/estrogene/progesterone biosynthesisP02727:Androgen/estrogene/progesterone biosynthesis
|
Pathway Interaction Database
|
BCR signaling pathway
|
Atypical NF-kappaB pathway
|
DNA-PK pathway in nonhomologous end joining
|
Presenilin action in Notch and Wnt signaling
|
Role of Calcineurin-dependent NFAT signaling in lymphocytes
|
E-cadherin signaling in the nascent adherens junction
|
Lissencephaly gene (LIS1) in neuronal migration and development
|
PDGFR-alpha signaling pathway
|
Signaling mediated by p38-alpha and p38-beta
|
Alpha-synuclein signalingsmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling
|
Coregulation of Androgen receptor activity
|
Regulation of Androgen receptor activity
|
Nongenotropic Androgen signaling
|
Regulation of nuclear beta catenin signaling and target gene transcription
|
FOXA1 transcription factor network
|
Notch-mediated HES/HEY networkp73pathway:p73 transcription factor network
|
C-MYB transcription factor network
|
IL2 signaling events mediated by STAT5
|
Regulation of retinoblastoma protein
|
PathWhiz Pathway
|
Fructose and Mannose Degradation
|
Pyruvate Metabolism
|
Pterine Biosynthesis
|
Glycerolipid Metabolism
|
Galactose MetabolismPW000045:Androgen and Estrogen MetabolismPW000045:Androgen and Estrogen Metabolism
|
Reactome
|
Condensation of Prometaphase ChromosomesR-HSA-211976:Endogenous sterolsR-HSA-211976:Endogenous sterolsR-HSA-383280:Nuclear Receptor transcription pathway
|
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3R-HSA-2559580:Oxidative Stress Induced Senescence
|
Senescence-Associated Secretory Phenotype (SASP)
|
Oncogene Induced Senescence
|
Cyclin D associated events in G1R-HSA-2453902:The canonical retinoid cycle in rods (twilight vision)
|
WikiPathways
|
Mitotic Prometaphase
|
BDNF signaling pathway
|
TNF alpha Signaling Pathway
|
L1CAM interactionsWP702:Metapathway biotransformation
|
Polyol Pathway
|
Metabolism of steroid hormones and vitamin DWP702:Metapathway biotransformation
|
Estrogen metabolism
|
Benzo(a)pyrene metabolism
|
Tamoxifen metabolism
|
Tryptophan metabolism
|
Oxidation by Cytochrome P450
|
Nuclear Receptors Meta-Pathway
|
Estrogen Receptor Pathway
|
Sulindac Metabolic Pathway
|
Arylhydrocarbon receptor (AhR) signaling pathway
|
miR-targeted genes in muscle cell - TarBase
|
miR-targeted genes in lymphocytes - TarBase
|
miR-targeted genes in epithelium - TarBase
|
miR-targeted genes in adipocytes - TarBase
|
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation
|
Ovarian Infertility Genes
|
Metabolism of steroid hormones and vitamin D
|
FSH signaling pathway
|
Integrated Breast Cancer Pathway
|
Phase 1 - Functionalization of compoundsWP706:SIDS Susceptibility Pathways
|
Integrated Pancreatic Cancer Pathway
|
Prostate Cancer
|
Nuclear Receptors
|
Androgen receptor signaling pathwayWP707:DNA Damage Response
|
G1 to S cell cycle control
|
Wnt Signaling Pathway Netpath
|
Retinoblastoma (RB) in Cancer
|
Signaling Pathways in Glioblastoma
|
Metastatic brain tumor
|
miR-targeted genes in leukocytes - TarBase
|
Mitotic G1-G1/S phases
|
Cell Cycle
|
miRNAs involved in DNA damage response
|
miRNA Regulation of DNA Damage ResponseWP496:Steroid Biosynthesis
|
References |
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4136). |
---|
REF 2 | Bioorg Med Chem. 2009 Oct 1;17(19):6816-23. Epub 2009 Aug 21.Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. |
---|
REF 3 | Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3. Epub 2009 Apr 22.Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid. |
---|
REF 4 | J Nat Prod. 2008 Apr;71(4):713-5. Epub 2008 Feb 26.Erigeroflavanone, a flavanone derivative from the flowers of Erigeron annuus with protein glycation and aldose reductase inhibitory activity. |
---|
REF 5 | Bioorg Med Chem. 2010 Sep 1;18(17):6310-5. Epub 2010 Jul 13.Selective inhibition of methoxyflavonoids on human CYP1B1 activity. |
---|
REF 6 | Bioorg Med Chem Lett. 2010 May 15;20(10):3050-64. Epub 2010 Apr 8.Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19). |
---|
REF 7 | Bioorg Med Chem Lett. 2009 Aug 15;19(16):4706-10. Epub 2009 Jun 23.Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay. |
---|
REF 8 | J Med Chem. 2004 Oct 21;47(22):5418-26.A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors. |
---|
REF 9 | J Med Chem. 2005 Feb 10;48(3):737-43.Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin. |
---|
REF 10 | J Med Chem. 2008 Jul 24;51(14):4188-99. Epub 2008 Jun 6.Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries. |